ヨーロッパの口唇ヘルペス治療市場 – 業界動向と2028年までの予測

Customize Your Report レポートをカスタマイズする Buy Now 今すぐ購入 Free Sample Report 無料サンプルレポート
Home Pharmaceutical ヨーロッパの口唇ヘルペス治療市場
Request for TOC TOC のリクエスト Speak to Analyst アナリストに相談する Buy Now今すぐ購入 Inquire Before Buying 事前に問い合わせる Free Sample Report 無料サンプルレポート

ヨーロッパの口唇ヘルペス治療市場 – 業界動向と2028年までの予測

  • Pharmaceutical
  • Published Report
  • Sep 2021
  • Europe
  • 350 ページ
  • テーブル数: 220
  • 図の数: 44
Buy Now 今すぐ購入

ヨーロッパの口唇ヘルペス治療市場

Market Size in USD Billion

CAGR :  % Diagram

Diagram 予測期間
 2021 –2028
Diagram 市場規模（基準年）
 USD 176.72 Million
Diagram Market Size (Forecast Year)
 USD 273.12 Million
Diagram CAGR
 %
Diagram 主要市場プレーヤー
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

>ヨーロッパの口唇ヘルペス治療市場、株タイプ別（単純ヘルペス1型ウイルスおよび単純ヘルペス2型ウイルス）、治療薬（抗ウイルス剤、鎮痛剤など）、薬剤タイプ別（ブランドおよびジェネリック）、投薬タイプ別（経口、局所など）、エンドユーザー別（病院、在宅ケア、専門クリニックなど）、流通チャネル別（病院薬局、小売薬局、オンライン薬局など）、国別（ドイツ、英国、フランス、イタリア、スペイン、ロシア、オランダ、スイス、ベルギー、トルコ、その他のヨーロッパ諸国）業界動向および2028年までの予測。

ヨーロッパの口唇ヘルペス治療市場

市場分析と洞察: ヨーロッパの口唇ヘルペス治療市場

口唇ヘルペス治療市場は、2021年から2028年の予測期間に市場成長を遂げると予想されています。データブリッジマーケットリサーチは、市場は2021年から2028年の予測期間に5.9％のCAGRで成長し、2021年の1億7,672万米ドルから2028年には2億7,312万米ドルに達すると分析しています。

単純ヘルペスウイルス（HSV）の世界的な蔓延とHSVの感染方法の急増は、予測期間中の市場の需要を推進する主な原動力です。

口唇ヘルペスまたは口唇ヘルペスは、単純ヘルペスウイルス (HSV) による感染が原因で生じる、擦り傷のような小さな水疱です。口唇ヘルペスは、一般的に顔、唇の周り、顎、頬、鼻孔に発生します。破裂する前に、痛みや痒みを伴うことがよくあります。HSV は、世界中の人々に感染する最も一般的なウイルスの 1 つであり、世界中で流行しています。世界中の人々の最大 90% が、少なくとも 1 つのタイプの HSV に感染しています。

単純ヘルペスウイルス (HSV) は、一般的に世界中の小児に感染しますが、WHO によると、30 歳から 49 歳の人は現在ウイルスに感染するリスクが高く、HSV の有病率は年齢とともに増加します。HSV には、HSV タイプ 1 と HSV タイプ 2 の 2 つのタイプがあります。HSV-1 は、唇、鼻孔、頬の周囲に口唇ヘルペスまたは口腔ヘルペスを引き起こします。一方、HSV-2 は性器ヘルペスを引き起こします。HSV は、口腔ヘルペスによる感染を誘発する口腔接触、正常に見え、症状がないときに口腔から皮膚表面への接触など、直接的な感染経路を通じて広がる可能性があります。

口唇ヘルペス治療市場レポートでは、市場シェア、新開発、製品パイプライン分析、国内および現地の市場プレーヤーの影響の詳細、新たな収益源、市場規制の変更、製品承認、戦略的決定、製品発売、地理的拡大、市場における技術革新の観点から見た機会の分析が提供されます。分析と市場シナリオを理解するには、アナリスト概要についてお問い合わせください。当社のチームが、希望する目標を達成するための収益影響ソリューションの作成をお手伝いします。

ヨーロッパの口唇ヘルペス治療市場ヨーロッパの口唇ヘルペス治療市場の範囲と市場規模

口唇ヘルペス治療市場は、菌株タイプ、治療タイプ、薬剤タイプ、投与量タイプ、エンドユーザー、流通チャネルに基づいて、6 つの主要なセグメントに分類されます。

  • 株の種類に基づいて、口唇ヘルペス治療市場は、単純ヘルペス1型ウイルスと単純ヘルペス2型ウイルスに分類されます。2021年には、急速に増加している有病率により、単純ヘルペス1型ウイルス（HSV）セグメントが市場を支配しています。
  • 治療薬の種類に基づいて、口唇ヘルペス治療市場は、抗ウイルス剤、鎮痛剤、その他に分類されます。2021年には、単純ヘルペスウイルスによって引き起こされる感染症の増加と、抗ウイルス剤の強化された製品パイプラインが市場を支配すると予測されているため、抗ウイルスセグメントが世界の口唇ヘルペス治療市場を支配すると予想されます。
  • 薬の種類に基づいて、口唇ヘルペス治療市場はブランド薬とジェネリック薬に分類されます。2021年には、ジェネリック薬が世界の口唇ヘルペス治療市場を支配しています。これは、ブランド薬に比べて非常に安価であり、経済的な性質と、世界中で口唇ヘルペスの治療に使用が増加しているためです。
  • 投与量の種類に基づいて、口唇ヘルペス治療市場は経口、局所、その他に分類されます。2021年には、吸収が容易でさまざまな種類の薬剤に対応できる柔軟性があるため、経口セグメントが世界の口唇ヘルペス治療市場を支配すると予想されます。
  • エンドユーザーに基づいて、口唇ヘルペス治療市場は、病院、在宅ケア、専門クリニック、その他に分類されます。2021年には、自宅での治療の容易さと薬の入手の容易さにより、在宅ケアセグメントが市場を支配しています。
  • 流通チャネルに基づいて、口唇ヘルペス治療市場は、病院薬局、小売薬局、オンライン薬局に分類されます。2021年には、口唇ヘルペス治療薬へのアクセスの増加と、毎日の口唇ヘルペス治療薬の処方数の急増により、病院薬局が市場を支配すると予想されます。

ヨーロッパの口唇ヘルペス治療市場口唇ヘルペス治療市場の国別分析

口唇ヘルペス治療市場は、菌株タイプ、治療タイプ、薬剤タイプ、投与量タイプ、エンドユーザー、流通チャネルに基づいて、6 つの主要なセグメントに分類されます。

口唇ヘルペス治療市場レポートで取り上げられている国は、ドイツ、イギリス、フランス、イタリア、スペイン、ロシア、オランダ、スイス、ベルギー、トルコ、その他のヨーロッパ諸国です。

ヨーロッパでは、患者数の急増と技術の進歩により、2021年から2028年の予測期間にドイツが最も有望な成長率で成長すると予想されています。性感染症に関する意識向上プログラムが口唇ヘルペス治療市場の牽引役となるため、フランスが優位になると予想されています。ただし、可処分所得の増加により、英国が優位になると予想されています。

レポートの国別セクションでは、市場の現在および将来の傾向に影響を与える国内市場における個別の市場影響要因と規制の変更も提供しています。新規販売、交換販売、国の人口統計、規制行為、輸出入関税などのデータ ポイントは、各国の市場シナリオを予測するために使用される主要な指標の一部です。また、国別データの予測分析を提供する際には、ヨーロッパ ブランドの存在と可用性、および地元および国内ブランドとの競争が激しいか少ないために直面​​する課題、販売チャネルの影響も考慮されます。  

メーカーによる戦略的取り組みが口唇ヘルペス治療市場のプレーヤーに新たな機会を創出 

口唇ヘルペス治療市場では、口唇ヘルペス治療の売上、口唇ヘルペス治療の進歩の影響、口唇ヘルペス治療市場への支援に伴う規制シナリオの変化など、美容産業における各国の成長に関する詳細な市場分析も提供しています。データは、2010年から2019年までの履歴期間について入手できます。  

競争環境と口唇ヘルペス治療市場シェア分析

口唇ヘルペス治療市場の競争状況は、競合他社ごとに詳細を提供します。含まれる詳細には、会社概要、会社の財務状況、収益、市場の可能性、研究開発への投資、新しい市場への取り組み、生産拠点と施設、会社の強みと弱み、製品の発売、製品試験パイプライン、製品の承認、特許、製品の幅と幅、アプリケーションの優位性、技術ライフライン曲線などがあります。提供されている上記のデータ ポイントは、口唇ヘルペス治療市場に関連する会社の焦点にのみ関連しています。

美容製品を提供する主要企業には、GlaxoSmithKline plc、Amneal Pharmaceuticals LLC、Sun Pharmaceutical Industries Ltd.、Zydus Pharmaceuticals, Inc.（Zydus Cadila の子会社）、Cipla Inc.、AiCuris、Teva Pharmaceuticals USA, Inc.（Teva Pharmaceutical Industries Ltd. の子会社）、Aurobindo Pharma USA（Aurobindo Pharma の子会社）、WOCKHARDT、Novartis AG、Hikma Pharmaceuticals PLC、Hetero Healthcare Limited、Apotex Inc.、HRA Pharma などがあります。DBMR アナリストは、競争上の強みを理解し、各競合他社の競合分析を個別に提供します。

世界中の企業によって多くの製品の発売や契約も開始されており、これも口唇ヘルペス治療市場の拡大を加速させています。

  • 2020年5月、テバ製薬工業株式会社は、COVID-19の状況を鑑み、株主、取締役、役員、従業員の健康と安全を考慮して、2020年の年次株主総会をオンラインで開催すると発表しました。これは、来年の戦略の策定と議論に役立つでしょう。

市場プレーヤーによるコラボレーション、ジョイントベンチャー、その他の戦略により、口唇ヘルペス治療市場における企業市場が強化され、組織にとっても口唇ヘルペス治療の提供を改善するメリットがもたらされます。  

SKU-

世界初のマーケットインテリジェンスクラウドに関するレポートにオンラインでアクセスする

Sample Image 画像をクリックすると拡大します
  • インタラクティブなデータ分析ダッシュボード
  • 成長の可能性が高い機会のための企業分析ダッシュボード
  • カスタマイズとクエリのためのリサーチアナリストアクセス
  • インタラクティブなダッシュボードによる競合分析
  • 最新ニュース、更新情報、トレンド分析
  • 包括的な競合追跡のためのベンチマーク分析のパワーを活用
デモのリクエスト

目次

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE Cold Sore Treatment MARKET
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. THERAPEUTICS LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. vendor share analysis
    11. MARKET drug type COVERAGE GRID
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. Pipeline analysis
  5. Epidemiology
  6. market overview
    1. drivers
      1. Growing prevalence of cold sore infection
      2. Proliferation in modes of transmission of herpes simplex virus
      3. Increasing awareness about sexually transmitted diseases
      4. Availability of generic drugs
      5. Rising rate of HSV infection among women
    2. RESTRAINTS
      1. Patent termination of marketed drugs
      2. Risks of other diseases associated with cold sore
      3. Dearth of awareness about the onset and symptoms of cold sore treatment
    3. OPPORTUNITIES
      1. Increasing disposable income
      2. Strategic Initiatives by market players
      3. Increasing research and Development
      4. Increasing use of cold sore patches
    4. CHALLENGES
      1. Rise in alternative treatments
      2. Emergence of drugs resistant to acyclovir
      3. Side effects Associated with medications used for treating cold sore
  7. COVID-19 IMPACT ON EUROPE COLD SORE TREATMENT MARKET
    1. impact on price
    2. Impact on demand
    3. IMPACT ON SUPPLY CHAIN
    4. strategic decisions for manufacturers
    5. CONCLUSION
  8. Europe COLD SORE TREATMENT MARKET, BY strain TYPE
    1. overview
    2. HERPES SIMPLEX TYPE 1 VIRUS
    3. HERPES SIMPLEX TYPE 2 VIRUS
  9. Europe COLD SORE TREATMENT MARKET, BY therapeutics
    1. overview
    2. ANTIVIRAL AGENTS
      1. Acyclovir
      2. Famciclovir
      3. Penciclovir
      4. Valacyclovir
      5. Docosanol
    3. ANALGESIC AGENTS
      1. Carmex
      2. Herpecin
      3. others
    4. others
  10. Europe COLD SORETREATMENT MARKET, BY drug type
    1. overview
    2. generics
      1. otc
    3. branded
      1. prescription
      2. otc
  11. Europe COLD SORE TREATMENT MARKET, BY dosage type
    1. overview
    2. Oral
    3. Tablets
    4. Pills
    5. TOPICAL
      1. cream
      2. Ointments
      3. Gel
      4. spray
    6. others
  12. Europe COLD SORE TREATMENT MARKET, BY end user
    1. overview
    2. HOme care
    3. HOspitals
    4. SPECIALTY CLINICS
    5. OTHERS
  13. Europe COLD SORE TREATMENT MARKET, BY DISTRIBUTION CHANNEL
    1. overview
    2. Hospitals Pharmacy
    3. online Pharmacy
    4. RETAIL Pharmacy
  14. EUROPE Cold sore treatment market, by Geography
    1. EUROPE
      1. germany
      2. france
      3. U.K.
      4. ITALY
      5. SPAIN
      6. RUSSIA
      7. SWITZERLAND
      8. NETHERLAND
      9. TURKEY
      10. IRELAND
      11. BELGIUM
      12. POLAND
      13. AUSTRIA
      14. NORWAY
      15. HUNGARY
      16. LITHUANIA
      17. REST OF EUROPE
  15. Europe Cold Sore Treatment Market: COMPANY landscape
    1. company share analysis: Europe
  16. SWOT
  17. company profile
    1. GLAXOSMITHKLINE PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    2. ORTHO DERMATOLOGICS’ (A DIVISION OF BAUSCH HEALTH COMPANIES INC.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    3. FOUNDATION CONSUMER HEALTHCARE
      1. COMPANY SNAPSHOT
      2. company share analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    4. NOVARTIS AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. company share analysis
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    5. TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICAL INDUSTRIES LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. AMNEAL PHARMACEUTICALS LLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. AICURIS GMBH & CO. KG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. APOTEX INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. AUROBINDO PHARMA USA (A SUBSIDIARY OF AUROBINDO PHARMA)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    10. CIPLA LIMITED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. GLENMARK PHARMACEUTICALS, INC., USA (A SUBSIDIARY OF GLENMARK PHARMACEUTICAL LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. HIKMA PHARMACEUTICALS PLC
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    13. HRA PHARMA
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    14. HETERO HEALTHCARE LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. JUBILANT CADISTA (A SUBSIDIARY OF JUBILANT LIFE SCIENCES LIMITED)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. MERIX PHARMACEUTICAL CORP.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. SQAUREX
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    18. SUN PHARMACEUTICAL INDUSTRIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. VIATRIS INC.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    20. WOCKHARDT
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    21. Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  18. questionnaire
  19. related reportS

表のリスト

TABLE 1 EuropeCOLD SORE TREATMENT Market, pipeline analysis

TABLE 2 GENERIC DRUGS USED FOR THE TREATMENT OF HSV (COLD SORES)

TABLE 3 Europe COLD SORE TREATMENT Market, By strain TYPE 2019-2028 (USD Million)

TABLE 4 Europe HERPES SIMPLEX TYPE 1 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 5 Europe HERPES SIMPLEX TYPE 2 VIRUS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 6 Europe COLD SORE TREATMENT Market, By THERAPEUTICS 2019-2028 (USD Million)

TABLE 7 Europe ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By region 2019-2028 (USD Million)

TABLE 8 Europe ANTIVIRAL AGENTS in COLD SORE TREATMENT Market, By therapeutics, 2019-2028 (USD Million)

TABLE 9 Europe ANALGESIC AGENTS in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)

TABLE 10 Europe Analgesic AGENTS in COLD SORE TREATMENT Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 11 Europe others in COLD SORE TREATMENT Market, By region, 2019-2028 (USD Million)

TABLE 12 Europe COLD SORE TREATMENT Market, By drug type 2019-2028 (USD Million)

TABLE 13 Europe generics in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 14 Europe generics in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 15 Europe branded in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 16 Europe branded in COLD SORE TREATMENT Market, By drug type, 2019-2028 (USD Million)

TABLE 17 Europe COLD SORE TREATMENT Market, By dosage type 2019-2028 (USD Million)

TABLE 18 Europe Oral in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 19 Europe Oral segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 20 Europe TOPICAL segment in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 21 Europe TOPICAL segment in COLD SORE TREATMENT Market, By dosage type, 2019-2028 (USD Million)

TABLE 22 Europe others in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 23 Europe COLD SORE TREATMENT Market, By END USER 2019-2028 (USD Million)

TABLE 24 Europe HOSPITALS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 25 Europe HOspitals in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 26 Europe SPECIALTY CLINICS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 27 Europe OTHERS in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 28 Europe COLD SORE TREATMENT Market, By distribution channel 2019-2028 (USD Million)

TABLE 29 Europe Hospitals Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 30 Europe ONLINE Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 31 Europe RETAIL Pharmacy in COLD SORE TREATMENT Market, By Region, 2019-2028 (USD Million)

TABLE 32 EUROPE Cold sore Market, By Country, 2019-2028 (USD Million)

TABLE 33 EUROPE Cold sore Market, By Strain, 2019-2028 (USD Million)

TABLE 34 EUROPE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 35 EUROPE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 36 EUROPE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 37 EUROPE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 38 EUROPE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 39 EUROPE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 40 EUROPE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 41 EUROPE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 42 EUROPE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 43 EUROPE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 44 EUROPE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 45 GERMANY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 46 GERMANY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 47 GERMANY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 48 GERMANY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 49 GERMANY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 50 GERMANY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 51 GERMANY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 52 GERMANY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 53 GERMANY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 54 GERMANY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 55 GERMANY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 56 GERMANY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 57 FRANCE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 58 FRANCE Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 59 FRANCE Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 60 FRANCE Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 61 FRANCE Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 62 FRANCE Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 63 FRANCE Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 64 FRANCE Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 65 FRANCE Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 66 FRANCE Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 67 FRANCE Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 68 FRANCE Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 69 U.K. Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 70 U.K. Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 71 U.K. Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 72 U.K. Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 73 U.K. Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 74 U.K. Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 75 U.K. Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 76 U.K. Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 77 U.K. Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 78 U.K. Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 79 U.K. Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 80 U.K. Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 81 ITALY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 82 ITALY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 83 ITALY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 84 ITALY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 85 ITALY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 86 ITALY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 87 ITALY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 88 ITALY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 89 ITALY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 90 ITALY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 91 ITALY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 92 ITALY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 93 SPAIN Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 94 SPAIN Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 95 SPAIN Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 96 SPAIN Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 97 SPAIN Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 98 SPAIN Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 99 SPAIN Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 100 SPAIN Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 101 SPAIN Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 102 SPAIN Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 103 SPAIN Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 104 SPAIN Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 105 RUSSIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 106 RUSSIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 107 RUSSIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 108 RUSSIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 109 RUSSIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 110 RUSSIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 111 RUSSIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 112 RUSSIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 113 RUSSIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 114 RUSSIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 115 RUSSIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 116 RUSSIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 117 SWITZERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 118 SWITZERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 119 SWITZERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 120 SWITZERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 121 SWITZERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 122 SWITZERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 123 SWITZERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 124 SWITZERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 125 SWITZERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 126 SWITZERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 127 SWITZERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 128 SWITZERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 129 NETHERLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 130 NETHERLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 131 NETHERLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 132 NETHERLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 133 NETHERLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 134 NETHERLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 135 NETHERLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 136 NETHERLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 137 NETHERLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 138 NETHERLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 139 NETHERLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 140 NETHERLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 141 TURKEY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 142 TURKEY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 143 TURKEY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 144 TURKEY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 145 TURKEY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 146 TURKEY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 147 TURKEY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 148 TURKEY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 149 TURKEY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 150 TURKEY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 151 TURKEY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 152 TURKEY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 153 IRELAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 154 IRELAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 155 IRELAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 156 IRELAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 157 IRELAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 158 IRELAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 159 IRELAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 160 IRELAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 161 IRELAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 162 IRELAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 163 IRELAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 164 IRELAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 165 BELGIUM Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 166 BELGIUM Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 167 BELGIUM Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 168 BELGIUM Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 169 BELGIUM Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 170 BELGIUM Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 171 BELGIUM Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 172 BELGIUM Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 173 BELGIUM Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 174 BELGIUM Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 175 BELGIUM Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 176 BELGIUM Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 177 POLAND Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 178 POLAND Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 179 POLAND Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 180 POLAND Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 181 POLAND Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 182 POLAND Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 183 POLAND Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 184 POLAND Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 185 POLAND Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 186 POLAND Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 187 POLAND Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 188 POLAND Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 189 AUSTRIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 190 AUSTRIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 191 AUSTRIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 192 AUSTRIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 193 AUSTRIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 194 AUSTRIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 195 AUSTRIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 196 AUSTRIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 197 AUSTRIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 198 AUSTRIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 199 AUSTRIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 200 AUSTRIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 201 NORWAY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 202 NORWAY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 203 NORWAY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 204 NORWAY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 205 NORWAY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 206 NORWAY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 207 NORWAY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 208 NORWAY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 209 NORWAY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 210 NORWAY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 211 NORWAY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 212 NORWAY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 213 HUNGARY Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 214 HUNGARY Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 215 HUNGARY Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 216 HUNGARY Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 217 HUNGARY Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 218 HUNGARY Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 219 HUNGARY Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 220 HUNGARY Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 221 HUNGARY Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 222 HUNGARY Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 223 HUNGARY Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 224 HUNGARY Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 225 LITHUANIA Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

TABLE 226 LITHUANIA Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 227 LITHUANIA Antiviral Agents in Cold Sore Treatment Market, By Therapeutics, 2019-2028 (USD Million)

TABLE 228 LITHUANIA Analgesic Agents in Cold Sore Treatment Market, By Therapeutics , 2019-2028 (USD Million)

TABLE 229 LITHUANIA Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 230 LITHUANIA Generics in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 231 LITHUANIA Branded in Cold Sore Treatment Market, By Drug Type, 2019-2028 (USD Million)

TABLE 232 LITHUANIA Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 233 LITHUANIA Oral in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 234 LITHUANIA Topical in Cold Sore Treatment Market, By Dosage Type, 2019-2028 (USD Million)

TABLE 235 LITHUANIA Cold Sore Treatment Market, By End User 2019-2028 (USD Million)

TABLE 236 LITHUANIA Cold Sore Treatment Market, By Distribution Channel 2019-2028 (USD Million)

TABLE 237 REST OF EUROPE Cold Sore Treatment Market, By Strain Type 2019-2028 (USD Million)

図表一覧

FIGURE 1 Europe COLD SORE TREATMENT MARKET: SEGMENTATION

FIGURE 2 EUROPE COLD SORE TREATMENT MARKET : DATA TRIANGULATION

FIGURE 3 Europe Cold Sore Treatment Market: DROC ANALYSIS

FIGURE 4 Europe Cold Sore Treatment market: Europe VS REGIONAL MARKET ANALYSIS

FIGURE 5 Europe Cold Sore Treatment Market: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE Cold Sore Treatment MARKET: MULTIVARIATE MODELLING

FIGURE 7 EUROPE Cold Sore Treatment MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 EUROPE COLD SORE TREATMENT MARKET: DBMR MARKET POSITION GRID

FIGURE 9 EUROPE COLD SORE TREATMENT MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 EUROPE Cold Sore Treatment MARKET: MARKET drug type COVERAGE GRID

FIGURE 11 Europe Cold Sore Treatment market: SEGMENTATION

FIGURE 12 Growing PREVALENCE OF COLD SORE TREATMENT WORLDWIDE, AND PROLIFERATION IN MODES OF TRANSMISSION of herpes simplex virus (hsv), and increasing awareness about sexually transmitted diseases are DRIVing THE Europe Cold Sore treatment market IN THE FORECAST PERIOD OF 2021 to 2028

FIGURE 13 HERPES SIMPLEX TYPE 1 VIRUS SEGMENT is expected to account for the largest share of the Europe COLD SORE TREATMENT MARKET in 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE COLD SORE TREATMENT MARKET

FIGURE 15 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, AMONG PERSONS AGED 14-49 YEARS, BY AGE GROUP: IN THE U.S. 2015–2016

FIGURE 16 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY RACE AND HISPANIC ORIGIN: U.S. 2015–2016

FIGURE 17 PREVALENCE OF HERPES SIMPLEX VIRUS TYPE 1, BY SEX: IN DIFFERENT COUNTRIES 2015–2016

FIGURE 18 Europe COLD SORE TREATMENT market: BY strain TYPE, 2020

FIGURE 19 Europe COLD SORE TREATMENT market: BY strain TYPE, 2020-2028 (USD Million)

FIGURE 20 Europe COLD SORE TREATMENT market: BY strain TYPE, CAGR (2021-2028)

FIGURE 21 Europe COLD SORE TREATMENT market: BY strain TYPE, LIFELINE CURVE

FIGURE 22 Europe COLD SORE TREATMENT market: BY THERAPEUTICS, 2020

FIGURE 23 Europe COLD SORE TREATMENT market: BY THERAPEUTICS , 2020-2028 (USD Million)

FIGURE 24 Europe COLD SORETREATMENT market: BY THERAPEUTICS, CAGR (2021-2028)

FIGURE 25 Europe COLD SORETREATMENT market: BY THERAPEUTICS, LIFELINE CURVE

FIGURE 26 Europe COLD SORETREATMENT market: BY drug type, 2020

FIGURE 27 Europe COLD SORETREATMENT market: BY drug type 2020-2028 (USD Million)

FIGURE 28 Europe COLD SORETREATMENT market: BY drug type, CAGR (2021-2028)

FIGURE 29 Europe COLD SORETREATMENT market: BY drug type, LIFELINE CURVE

FIGURE 30 Europe COLD SORETREATMENT market: BY dosage type, 2020

FIGURE 31 Europe COLD SORETREATMENT market: BY dosage type 2020-2028 (USD Million)

FIGURE 32 Europe COLD SORETREATMENT market: BY dosage type, CAGR (2021-2028)

FIGURE 33 Europe COLD SORETREATMENT market: BY dosage type, LIFELINE CURVE

FIGURE 34 Europe COLD SORE TREATMENT market: BY END USER, 2020

FIGURE 35 Europe COLD SORE TREATMENT market: BY END USER 2020-2028 (USD Million)

FIGURE 36 Europe COLD SORE TREATMENT market: BY END USER, CAGR (2021-2028)

FIGURE 37 Europe COLD SORE TREATMENT market: BY END USER, LIFELINE CURVE

FIGURE 38 Europe COLD SORE TREATMENT market: BY distribution channel, 2020

FIGURE 39 Europe COLD SORE TREATMENT market: BY distribution channel 2020-2028 (USD Million)

FIGURE 40 Europe COLD SORE TREATMENT market: BY distribution channel, CAGR (2021-2028)

FIGURE 41 Europe COLD SORE TREATMENT market: BY distribution channel, LIFELINE CURVE

FIGURE 42 EUROPE cold sore treatment market: SNAPSHOT (2020)

FIGURE 43 EUROPE cold sore treatment market: BY COUNTRY (2020)

FIGURE 44 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 45 EUROPE cold sore treatment market: BY COUNTRY (2021 & 2028)

FIGURE 46 EUROPE cold sore treatment market: BY strains (2021-2028)

FIGURE 47 Europe cold sore treatment market: company share 2020 (%)

詳細情報を見る Right Arrow

調査方法

データ収集と基準年分析は、大規模なサンプル サイズのデータ​​収集モジュールを使用して行われます。この段階では、さまざまなソースと戦略を通じて市場情報または関連データを取得します。過去に取得したすべてのデータを事前に調査および計画することも含まれます。また、さまざまな情報ソース間で見られる情報の不一致の調査も含まれます。市場データは、市場統計モデルと一貫性モデルを使用して分析および推定されます。また、市場シェア分析と主要トレンド分析は、市場レポートの主要な成功要因です。詳細については、アナリストへの電話をリクエストするか、お問い合わせをドロップダウンしてください。

DBMR 調査チームが使用する主要な調査方法は、データ マイニング、データ変数が市場に与える影響の分析、および一次 (業界の専門家) 検証を含むデータ三角測量です。データ モデルには、ベンダー ポジショニング グリッド、市場タイムライン分析、市場概要とガイド、企業ポジショニング グリッド、特許分析、価格分析、企業市場シェア分析、測定基準、グローバルと地域、ベンダー シェア分析が含まれます。調査方法について詳しくは、お問い合わせフォームから当社の業界専門家にご相談ください。

カスタマイズ可能

Data Bridge Market Research は、高度な形成的調査のリーダーです。当社は、既存および新規のお客様に、お客様の目標に合致し、それに適したデータと分析を提供することに誇りを持っています。レポートは、対象ブランドの価格動向分析、追加国の市場理解 (国のリストをお問い合わせください)、臨床試験結果データ、文献レビュー、リファービッシュ市場および製品ベース分析を含めるようにカスタマイズできます。対象競合他社の市場分析は、技術ベースの分析から市場ポートフォリオ戦略まで分析できます。必要な競合他社のデータを、必要な形式とデータ スタイルでいくつでも追加できます。当社のアナリスト チームは、粗い生の Excel ファイル ピボット テーブル (ファクト ブック) でデータを提供したり、レポートで利用可能なデータ セットからプレゼンテーションを作成するお手伝いをしたりすることもできます。

Frequently Asked Questions

The market is segmented based on , By Strain Type (Herpes Simplex Type-1 Virus and Herpes Simplex Type-2 Virus), Therapeutics (Antiviral Agents, Analgesic Agents and Others), Drug Type (Branded and Generic), Dosage Type (Oral, Topical and Others), End User (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others), Country (Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and Rest of Europe) Industry Trends and Forecast to 2028. .
The Europe Cold Sore Treatment Market size was valued at USD 176.72 USD Million in 2020.
The Europe Cold Sore Treatment Market is projected to grow at a CAGR of 5.9% during the forecast period of 2021 to 2028.

関連ページを閲覧する

Banner